Phase II Study of Amrubicin Combined with Carboplatin for Thymic Carcinoma and Invasive Thymoma: North Japan Lung Cancer Group Study 0803Akira Inoue, Toshihiro Nukiwa, Toshiyuki Kozuki et al.|Journal of Thoracic Oncology|2014Cited by 46
Phase II study of amrubicin (AMR) and carboplatin (CBDCA) for invasive thymoma (IT) and thymic carcinoma (TC): NJLCG0803.Yosuke Kawashima, Toshihiro Nukiwa, Akira Inoue et al.|Journal of Clinical Oncology|2013Cited by 6